EMBCEmbecta
+3.6% today · −52.0% over a year
3/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 46% of the instruments we score
Trend: among the weakest; priced lower than most peers. Dividend yield 4.99%.
Embecta (EMBC) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €324.5M. Over the past 12 months the price changed by −52.0%, with an annualised volatility of 103% and a largest fall of 80%.
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in USA (n = 338)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Gross profit growth / assets (5 y)weighs on the score · better than 2% of peers
- 12-month trend (ex last month)weighs on the score · better than 2% of peers
- Volatility (1 y)weighs on the score · better than 6% of peers
Red flags and notes
- Caution. Net debt above 4× EBITDA or interest cover below 2×. More in the glossary → Net debt above 4× EBITDA or interest cover below 2×.
- Caution. Book equity is below zero. More in the glossary → Book equity is below zero.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/E
- 4.2
- P/S
- 0.4
- EV/EBIT
- 7.2
- Free-cash-flow yield
- 45.3%
- Market cap (EUR)
- €324.5M
Profitability and debt
- Return on invested capital
- 25.4%
- Gross margin
- 59.0%
- Net debt / EBITDA
- 4.69
Dividends
- Dividend yield
- 4.99%
- Payout ratio
- 22%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +3.6%
- 1 month
- +12.8%
- 1 year
- −52.0%
- Volatility, 1 yr
- 103.4%
- Max drawdown, 1 yr
- −79.6%
- Beta
- 0.85
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| ALECAlector | 1/10 | 0.0% | 92.2% |
|---|---|---|---|
| ALLOAllogene Therapeutics Inc | —/10 | 0.0% | −10.2% |
| AVIRAtea Pharmaceuticals | —/10 | 0.0% | 34.9% |
| ENTAEnanta Pharmaceuticals Inc | —/10 | 0.0% | 4.4% |
| OFIXOrthofix Medical Inc | 1/10 | 0.0% | −47.2% |
| ALTAltimmune | 1/10 | 0.0% | −48.4% |
| EBSEmergent BioSolutions Inc | 1/10 | 0.0% | −40.0% |
| EDITEditas Medicine Inc | 1/10 | 0.0% | 11.3% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 5 entries
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | 3/10 | 3 · 1 | — | Available with Invest Pro | |
| Rating change | 3/10 | 4 · 1 | — | Available with Invest Pro | |
| Rating change | 2 → 3/10 | 3 · 1 | — | Available with Invest Pro | |
| Rating change | 2/10 | 2 · 1 | — | Available with Invest Pro | |
| First rating | 2/10 | 3 · 1 | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.